Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015

Authors: Pedro Torres-Gonzalez, Miguel E. Cervera-Hernandez, Areli Martinez-Gamboa, Lourdes Garcia-Garcia, Luis P. Cruz-Hervert, Miriam Bobadilla-del Valle, Alfredo Ponce-de Leon, Jose Sifuentes-Osornio

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Human tuberculosis caused by Mycobacterium bovis is believed to be frequent in developing countries. Transmission is usually through ingestion of unpasteurized dairy products, although airborne contagion is possible. Disease caused by M. tuberculosis or M. bovis is clinically indistinguishable from each other. The aim of this study was to determine the factors associated with M. bovis disease.

Methods

Retrospective analysis of all culture-positive cases of M. bovis and M. tuberculosis from 2000 to 2015, in a Mexican tertiary-care centre. Sociodemographic, clinical, and radiographic data from medical records were compared. Disease site was classified as pulmonary, extrapulmonary, or pulmonary and extrapulmonary, based on cultures.

Results

We evaluated 533 cases, 372 (69.7 %) of which were caused by M. tuberculosis and 161 (30.2 %) by M. bovis. Characteristics associated with M. bovis disease were: younger age (aOR 0.97, 95 % CI 0.95–0.98), glucocorticoid use (aOR 2.27, 95 % CI 1.42–3.63), and extrapulmonary disease (aOR 1.80, 95 % CI 1.21–2.69). M. tuberculosis was associated with lower socioeconomic status (aOR 0.52, 95 % CI 0.28–0.97). When we analysed only pulmonary cases, younger age (aOR 0.97, 95 % CI 0.96–0.99), glucocorticoid use (aOR 2.41, 95 % CI 1.30–4.46), and smoking (aOR 1.94, CI 95 % 1.15–3.27) were associated with M. bovis. Both groups showed similar proportions of direct microscopy smear results (respiratory samples) and chest X-ray cavitations.

Conclusions

Younger age, glucocorticoid use, and extrapulmonary disease were associated with M. bovis as the causative agent of tuberculosis in a group of patients from a tertiary care centre in a country where bovine tuberculosis is endemic. Further studies must be conducted in the general population to determine pathogen-specific associated factors and outcomes.
Literature
1.
go back to reference Cosivi O, Grange JM, Daborn CJ, Raviglione MC, Fujikura T, Cousins D, Robinson RA, Huchzermeyer HF, de Kantor I, Meslin FX. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis. 1998;4:59–70.CrossRefPubMedPubMedCentral Cosivi O, Grange JM, Daborn CJ, Raviglione MC, Fujikura T, Cousins D, Robinson RA, Huchzermeyer HF, de Kantor I, Meslin FX. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis. 1998;4:59–70.CrossRefPubMedPubMedCentral
2.
go back to reference de la Rua-Domenech R. Human Mycobacterium bovis infection in the United Kingdom: Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis (Edinb). 2006;86:77–109.CrossRef de la Rua-Domenech R. Human Mycobacterium bovis infection in the United Kingdom: Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis (Edinb). 2006;86:77–109.CrossRef
3.
go back to reference Bobadilla-del Valle M, Torres-Gonzalez P, Cervera-Hernandez ME, Martinez-Gamboa A, Crabtree-Ramirez B, Chavez-Mazari B, Ortiz-Conchi N, Rodriguez-Cruz L, Cervantes-Sanchez A, Gudino-Enriquez T, et al. Trends of mycobacterium bovis isolation and first-line anti-tuberculosis drug susceptibility profile: a fifteen-year laboratory-based surveillance. PLoS Negl Trop Dis. 2015;9:e0004124.CrossRefPubMedPubMedCentral Bobadilla-del Valle M, Torres-Gonzalez P, Cervera-Hernandez ME, Martinez-Gamboa A, Crabtree-Ramirez B, Chavez-Mazari B, Ortiz-Conchi N, Rodriguez-Cruz L, Cervantes-Sanchez A, Gudino-Enriquez T, et al. Trends of mycobacterium bovis isolation and first-line anti-tuberculosis drug susceptibility profile: a fifteen-year laboratory-based surveillance. PLoS Negl Trop Dis. 2015;9:e0004124.CrossRefPubMedPubMedCentral
4.
go back to reference Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis (Edinb). 2001;81:71–7.CrossRef Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis (Edinb). 2001;81:71–7.CrossRef
5.
go back to reference Konno K, Feldmann FM, McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967;95:461–9.PubMed Konno K, Feldmann FM, McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967;95:461–9.PubMed
6.
go back to reference LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994–2003. Int J Tuberc Lung Dis. 2005;9:333–8.PubMed LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994–2003. Int J Tuberc Lung Dis. 2005;9:333–8.PubMed
7.
go back to reference LoBue PA, LeClair JJ, Moser KS. Contact investigation for cases of pulmonary Mycobacterium bovis. Int J Tuberc Lung Dis. 2004;8:868–72.PubMed LoBue PA, LeClair JJ, Moser KS. Contact investigation for cases of pulmonary Mycobacterium bovis. Int J Tuberc Lung Dis. 2004;8:868–72.PubMed
8.
go back to reference Guerrero A, Cobo J, Fortun J, Navas E, Quereda C, Asensio A, Canon J, Blazquez J, Gomez-Mampaso E. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet. 1997;350:1738–42.CrossRefPubMed Guerrero A, Cobo J, Fortun J, Navas E, Quereda C, Asensio A, Canon J, Blazquez J, Gomez-Mampaso E. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet. 1997;350:1738–42.CrossRefPubMed
9.
go back to reference Evans JT, Smith EG, Banerjee A, Smith RM, Dale J, Innes JA, Hunt D, Tweddell A, Wood A, Anderson C, et al. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet. 2007;369:1270–6.CrossRefPubMed Evans JT, Smith EG, Banerjee A, Smith RM, Dale J, Innes JA, Hunt D, Tweddell A, Wood A, Anderson C, et al. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet. 2007;369:1270–6.CrossRefPubMed
10.
go back to reference Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, Crawford JT, Lobue PA. Human tuberculosis due to Mycobacterium bovis in the United States, 1995–2005. Clin Infect Dis. 2008;47:168–75.CrossRefPubMed Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, Crawford JT, Lobue PA. Human tuberculosis due to Mycobacterium bovis in the United States, 1995–2005. Clin Infect Dis. 2008;47:168–75.CrossRefPubMed
11.
12.
go back to reference Majoor CJ, Magis-Escurra C, van Ingen J, Boeree MJ, van Soolingen D. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993–2007. Emerg Infect Dis. 2011;17:457–63.CrossRefPubMedPubMedCentral Majoor CJ, Magis-Escurra C, van Ingen J, Boeree MJ, van Soolingen D. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993–2007. Emerg Infect Dis. 2011;17:457–63.CrossRefPubMedPubMedCentral
13.
go back to reference LoBue PA, Betacourt W, Peter C, Moser KS. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994–2000. Int J Tuberc Lung Dis. 2003;7:180–5.PubMed LoBue PA, Betacourt W, Peter C, Moser KS. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994–2000. Int J Tuberc Lung Dis. 2003;7:180–5.PubMed
14.
go back to reference Park D, Qin H, Jain S, Preziosi M, Minuto JJ, Mathews WC, Moser KS, Benson CA. Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus. Clin Infect Dis. 2010;51:1343–6.CrossRefPubMed Park D, Qin H, Jain S, Preziosi M, Minuto JJ, Mathews WC, Moser KS, Benson CA. Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus. Clin Infect Dis. 2010;51:1343–6.CrossRefPubMed
15.
go back to reference Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis. 2008;14:909–16.CrossRefPubMedPubMedCentral Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis. 2008;14:909–16.CrossRefPubMedPubMedCentral
16.
go back to reference Baez-Saldana R, Villafuerte-Garcia A, Cruz-Hervert P, Delgado-Sanchez G, Ferreyra-Reyes L, Ferreira-Guerrero E, Mongua-Rodriguez N, Montero-Campos R, Melchor-Romero A, Garcia-Garcia L. Association between highly active antiretroviral therapy and type of infectious respiratory disease and All-cause in-hospital mortality in patients with HIV/AIDS: a case series. PLoS One. 2015;10:e0138115.CrossRefPubMedPubMedCentral Baez-Saldana R, Villafuerte-Garcia A, Cruz-Hervert P, Delgado-Sanchez G, Ferreyra-Reyes L, Ferreira-Guerrero E, Mongua-Rodriguez N, Montero-Campos R, Melchor-Romero A, Garcia-Garcia L. Association between highly active antiretroviral therapy and type of infectious respiratory disease and All-cause in-hospital mortality in patients with HIV/AIDS: a case series. PLoS One. 2015;10:e0138115.CrossRefPubMedPubMedCentral
18.
go back to reference Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49:1–51. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49:1–51.
19.
go back to reference Vestal AL. Procedures for the isolation and identification of mycobacteria. 1st ed. Washington: United States Government Printing Office; 1969. Vestal AL. Procedures for the isolation and identification of mycobacteria. 1st ed. Washington: United States Government Printing Office; 1969.
20.
go back to reference Lennette EH, Spaulding EH, Truant JP. Manual of clinical microbiology. 2dth ed. Washington: American Society for Microbiology; 1974. Lennette EH, Spaulding EH, Truant JP. Manual of clinical microbiology. 2dth ed. Washington: American Society for Microbiology; 1974.
21.
go back to reference Balows A. Manual of clinical microbiology. 5th ed. Washington, D.C.: American Society for Microbiology; 1991. Balows A. Manual of clinical microbiology. 5th ed. Washington, D.C.: American Society for Microbiology; 1991.
22.
go back to reference Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.PubMedPubMedCentral Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.PubMedPubMedCentral
23.
go back to reference Richter E, Weizenegger M, Fahr AM, Rusch-Gerdes S. Usefulness of the GenoType MTBC assay for differentiating species of the Mycobacterium tuberculosis complex in cultures obtained from clinical specimens. J Clin Microbiol. 2004;42:4303–6.CrossRefPubMedPubMedCentral Richter E, Weizenegger M, Fahr AM, Rusch-Gerdes S. Usefulness of the GenoType MTBC assay for differentiating species of the Mycobacterium tuberculosis complex in cultures obtained from clinical specimens. J Clin Microbiol. 2004;42:4303–6.CrossRefPubMedPubMedCentral
24.
go back to reference Jonsson J, Hoffner S, Berggren I, Bruchfeld J, Ghebremichael S, Pennhag A, Groenheit R. Comparison between RFLP and MIRU-VNTR genotyping of Mycobacterium tuberculosis strains isolated in Stockholm 2009 to 2011. PLoS One. 2014;9:e95159.CrossRefPubMedPubMedCentral Jonsson J, Hoffner S, Berggren I, Bruchfeld J, Ghebremichael S, Pennhag A, Groenheit R. Comparison between RFLP and MIRU-VNTR genotyping of Mycobacterium tuberculosis strains isolated in Stockholm 2009 to 2011. PLoS One. 2014;9:e95159.CrossRefPubMedPubMedCentral
25.
go back to reference Cordova E, Gonzalo X, Boschi A, Lossa M, Robles M, Poggi S, Ambroggi M. Human Mycobacterium bovis infection in Buenos Aires: epidemiology, microbiology and clinical presentation. Int J Tuberc Lung Dis. 2012;16(3):415–7.CrossRefPubMed Cordova E, Gonzalo X, Boschi A, Lossa M, Robles M, Poggi S, Ambroggi M. Human Mycobacterium bovis infection in Buenos Aires: epidemiology, microbiology and clinical presentation. Int J Tuberc Lung Dis. 2012;16(3):415–7.CrossRefPubMed
26.
go back to reference Lopez-Alvarez R, Badillo-Lopez C, Cerna-Cortes JF, Castillo-Ramirez I, Rivera-Gutierrez S, Helguera-Repetto AC, Aguilar D, Hernandez-Pando R, Samper S, Gonzalez-y-Merchand JA. First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance. BMC Microbiol. 2010;10:82.CrossRefPubMedPubMedCentral Lopez-Alvarez R, Badillo-Lopez C, Cerna-Cortes JF, Castillo-Ramirez I, Rivera-Gutierrez S, Helguera-Repetto AC, Aguilar D, Hernandez-Pando R, Samper S, Gonzalez-y-Merchand JA. First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance. BMC Microbiol. 2010;10:82.CrossRefPubMedPubMedCentral
27.
go back to reference Pereira-Suárez AL, Estrada-Chávez Y, Zúñiga-Estrada A, Lopez-Rincón G, Hernández DU, Padilla-Ramírez FJ, Estrada-Chávez C. Detection of Mycobacterium tuberculosis complex by PCR in fresh cheese from local markets in Hidalgo. Mexico J Food Prot. 2014;77(5):849–52.CrossRefPubMed Pereira-Suárez AL, Estrada-Chávez Y, Zúñiga-Estrada A, Lopez-Rincón G, Hernández DU, Padilla-Ramírez FJ, Estrada-Chávez C. Detection of Mycobacterium tuberculosis complex by PCR in fresh cheese from local markets in Hidalgo. Mexico J Food Prot. 2014;77(5):849–52.CrossRefPubMed
28.
go back to reference Grange JM, Daborn C, Cosivi O. HIV-related tuberculosis due to Mycobacterium bovis. Eur Respir J. 1994;7:1564–6.CrossRefPubMed Grange JM, Daborn C, Cosivi O. HIV-related tuberculosis due to Mycobacterium bovis. Eur Respir J. 1994;7:1564–6.CrossRefPubMed
29.
go back to reference Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006;55:19–26.CrossRefPubMed Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006;55:19–26.CrossRefPubMed
30.
go back to reference O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527.CrossRefPubMed O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527.CrossRefPubMed
32.
go back to reference Torres-Gonzalez P, Soberanis-Ramos O, Martinez-Gamboa A, Chavez-Mazari B, Barrios-Herrera MT, Torres-Rojas M, Cruz-Hervert LP, Garcia-Garcia L, Singh M, Gonzalez-Aguirre A, et al. Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoS Negl Trop Dis. 2013;7:e2177.CrossRefPubMedPubMedCentral Torres-Gonzalez P, Soberanis-Ramos O, Martinez-Gamboa A, Chavez-Mazari B, Barrios-Herrera MT, Torres-Rojas M, Cruz-Hervert LP, Garcia-Garcia L, Singh M, Gonzalez-Aguirre A, et al. Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoS Negl Trop Dis. 2013;7:e2177.CrossRefPubMedPubMedCentral
33.
go back to reference Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68:2240–6.CrossRefPubMed Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68:2240–6.CrossRefPubMed
34.
go back to reference Berg S, Smith NH. Why doesn’t bovine tuberculosis transmit between humans? Trends Microbiol. 2014;22:552–3.CrossRefPubMed Berg S, Smith NH. Why doesn’t bovine tuberculosis transmit between humans? Trends Microbiol. 2014;22:552–3.CrossRefPubMed
35.
go back to reference Gambhir HS, Kaushik RM, Kaushik R, Sindhwani G. Tobacco smoking-associated risk for tuberculosis: a case–control study. Int Health. 2010;2:216–22.CrossRefPubMed Gambhir HS, Kaushik RM, Kaushik R, Sindhwani G. Tobacco smoking-associated risk for tuberculosis: a case–control study. Int Health. 2010;2:216–22.CrossRefPubMed
36.
go back to reference Bonacci RA, Cruz-Hervert LP, Garcia-Garcia L, Reynales-Shigematsu LM, Ferreyra-Reyes L, Bobadilla-del-Valle M, Canizales-Quintero S, Ferreira-Guerrero E, Baez-Saldana R, Tellez-Vazquez N, et al. Impact of cigarette smoking on rates and clinical prognosis of pulmonary tuberculosis in Southern Mexico. J Infect. 2013;66:303–12.CrossRefPubMed Bonacci RA, Cruz-Hervert LP, Garcia-Garcia L, Reynales-Shigematsu LM, Ferreyra-Reyes L, Bobadilla-del-Valle M, Canizales-Quintero S, Ferreira-Guerrero E, Baez-Saldana R, Tellez-Vazquez N, et al. Impact of cigarette smoking on rates and clinical prognosis of pulmonary tuberculosis in Southern Mexico. J Infect. 2013;66:303–12.CrossRefPubMed
37.
go back to reference Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007;167:335–42.CrossRefPubMed Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007;167:335–42.CrossRefPubMed
38.
go back to reference Chuang HC, Su CL, Liu HC, Feng PH, Lee KY, Chuang KJ, Lee CN, Bien MY. Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis. Ther Clin Risk Manag. 2015;11:1539–44.CrossRefPubMedPubMedCentral Chuang HC, Su CL, Liu HC, Feng PH, Lee KY, Chuang KJ, Lee CN, Bien MY. Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis. Ther Clin Risk Manag. 2015;11:1539–44.CrossRefPubMedPubMedCentral
39.
go back to reference Kurbatova EV, Cavanaugh JS, Dalton T, Click ES, Cegielski JP. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999–2009. Clin Infect Dis. 2014;57:1081–93.CrossRef Kurbatova EV, Cavanaugh JS, Dalton T, Click ES, Cegielski JP. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999–2009. Clin Infect Dis. 2014;57:1081–93.CrossRef
40.
go back to reference Centers for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis-New York City, 2001–2004. Morb Mortal Wkly Rep. 2005;54:605–8. Centers for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis-New York City, 2001–2004. Morb Mortal Wkly Rep. 2005;54:605–8.
Metadata
Title
Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015
Authors
Pedro Torres-Gonzalez
Miguel E. Cervera-Hernandez
Areli Martinez-Gamboa
Lourdes Garcia-Garcia
Luis P. Cruz-Hervert
Miriam Bobadilla-del Valle
Alfredo Ponce-de Leon
Jose Sifuentes-Osornio
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2001-5

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.